Target intelligence / Profile preview

Septin 14 pseudogene 4 (SEPTIN14P4)

Target
SEPTIN14P4
Molecular classification
Other (pseudogene)
01

Overview

Septin 14 pseudogene 4 (SEPTIN14P4) is a pseudogene—an inactive or nonfunctional DNA sequence derived from the SEPTIN14 gene. Pseudogenes, by definition, are segments of DNA that resemble functional genes but contain mutations or other sequence alterations that prevent them from producing functional proteins[1][4][6]. Like other pseudogenes, SEPTIN14P4 does not encode an active protein and is not considered a receptor, enzyme, transporter, or other classical drug target. While most pseudogenes are considered molecular "dead ends," there is emerging evidence that some can have regulatory impacts on cell biology, for example by acting as RNA decoys, influencing gene expression via microRNA competition, or occasionally by being sources of regulatory noncoding RNAs[2][3]. However, there is currently no specific evidence that SEPTIN14P4 itself has such regulatory functions or disease relevance. Therefore, "Septin 14 pseudogene 4" (SEPTIN14P4) is not a true therapeutic target, is not functionally active, and does not possess known aliases, drugs, mechanisms of action, or safety concerns documented in the scientific literature.

02

Mechanism of action

None; not targeted by drugs.

03

Biological functions

No inherent protein-coding function; may have some regulatory, noncoding RNA-related, or gene expression modulator roles, as is described for some pseudogenes in the literature
04

Disease associations

Other (no direct evidence for a specific disease association or established pathological role), though some pseudogenes can be involved indirectly in diseases via regulatory functions

Beyond the preview

Go deeper on Septin 14 pseudogene 4 (SEPTIN14P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Septin 14 pseudogene 4 (SEPTIN14P4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call